Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

Businessweek quotes Harry Glorikian in "GE, Bayer Loom Over Avid's Lead in Creating Alzheimer's Test"

Elizabeth Lopatto and Kanoko Matsuyama
July 9, 2010

For this article covering the head-to-head Alzheimer's diagnostics race between Avid, GE and Bayer, Bloomberg's reporters interviewed Harry Glorikian to better understand what will count in determining which company will dominate the market. All three health care companies are developing chemical dyes to identify proteins in the brain, that are markers for Alzheimer's. "While Avid has a head start over GE and Bayer, in testing at earlier stages, it doesn't assure long-term market dominance," according to Scientia Advisors.

Read more about what competitive strengths each health care company brings to the diagnostics race at: Bloomberg Businessweek